Qlucore has agreed a two-year license with the Boehringer Ingelheim worth approximately SEK 1.67 million. As a leading pharmaceutical company engaged in research and development across multiple locations worldwide and a previous customer of Qlucore, the license enables global utilization of Qlucore Omics Explorer software. Qlucore Omics Explorer is software designed for research in pharmaceuticals and biotechnology, catering to both commercial and academic users.

Through interactive visualization coupled with rapid calculations, users can identify crucial information within often vast and complex datasets. The software is currently utilized by researchers in over 200 organizations across more than 20 countries, to publish over 1,000 scientific articles.